Buck, E., Gaida, M., Grüllich, C., Weber, T., Bruckner, T., & Koschny, R. (2019). Tumor response to irinotecan is associated with CYP3A5 expression in colorectal cancer. Oncology letters, 17(4), . https://doi.org/10.3892/ol.2019.10043
Chicago Style (17th ed.) CitationBuck, Emanuel, Matthias Gaida, Carsten Grüllich, Tim Weber, Thomas Bruckner, and Ronald Koschny. "Tumor Response to Irinotecan Is Associated with CYP3A5 Expression in Colorectal Cancer." Oncology Letters 17, no. 4 (2019). https://doi.org/10.3892/ol.2019.10043.
MLA (9th ed.) CitationBuck, Emanuel, et al. "Tumor Response to Irinotecan Is Associated with CYP3A5 Expression in Colorectal Cancer." Oncology Letters, vol. 17, no. 4, 2019, https://doi.org/10.3892/ol.2019.10043.
Warning: These citations may not always be 100% accurate.